top of page
Executive Spotlights

Conventus Flower Orthopedics Appoints Bradley Niemann as Chief Executive Officer

Horsham, PA., July 19, 2022 (PRNewswire) — Conventus Flower Orthopedics, a privately held medical technology company that pioneered the Ready-for-Surgery™ single-use, sterile packaged foot and ankle solutions and launched the first-to-market flexible intramedullary distal fibula nail, today announced that Brad Niemann has been appointed as the Company’s Chief Executive Officer (CEO), effective immediately.

“The Board of Directors and Deerfield Management are pleased to have an incredible leader like Brad join Conventus Flower Orthopedics,” said Rick Epstein, Chairman of the Board. “His proven leadership, strong operational expertise, and extensive experience managing significant growth will be invaluable to the Company as we continue to launch new, highly differentiated products.”


Niemann’s experience spans nearly 25 years of executive management in the medical device industry. Previously, he held multiple leadership positions at Orthofix International N.V, a global medical device company focused on musculoskeletal products and therapies. He joined Orthofix in 2012 as Senior Vice President, Commercial Operations. He was promoted to President, BioStim in 2013 and to President of Global Orthofix Spine in 2018. Prior to joining Orthofix, he held various leadership positions at DJO Global, Inc. including Senior Vice President of Recovery Sciences, where he led their commercial team and aided in M&A efforts.


“I am thrilled to join the Conventus Flower Orthopedics team,” said Niemann. “There is an incredible energy among the Conventus Flower leadership team, and I am excited and honored to continue the momentum the team has established in the market. The Company’s core products, innovative new products within the Flex-Thread™ portfolio, and the expanding pipeline set the organization up for continued growth.”

“We are excited to share this fantastic news with our distribution teams and surgeon customers,” said Jeff Zanni, Chief Commercial Officer. “Conventus Flower Orthopedics is rapidly capturing market share with our unique and differentiated technologies, and Brad’s leadership will further accelerate our ability to provide measurable value to our end users.”


Recent Posts

See All
Life Science Headlines
bottom of page